Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127252) titled 'Application of a Prostate MRI Reliable Joint Segmentation System Based on Conformal Prediction in Biopsy Decision-Making' on June 28.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of Kunming Medical University
Condition:
prostate cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-01
Target Sample Size: Observation group:180;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=329414
Published by HT Digital Content Services with permission from Health Daily Diges...